{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "29978-587",
      "generic_name": "Dextromethorphan Hydrobromide, Guaifenesin and Phenylephrine Hydrochloride",
      "labeler_name": "Capital Pharmaceutical, LLC",
      "brand_name": "Aquanaz",
      "active_ingredients": [
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "15 mg/1"
        },
        {
          "name": "GUAIFENESIN",
          "strength": "400 mg/1"
        },
        {
          "name": "PHENYLEPHRINE HYDROCHLORIDE",
          "strength": "10 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "29978-587-01",
          "description": "100 TABLET in 1 BOTTLE (29978-587-01)",
          "marketing_start_date": "20150310",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Capital Pharmaceutical, LLC"
        ],
        "rxcui": [
          "1552200"
        ],
        "spl_set_id": [
          "5e9e4dfd-4def-4756-9bba-d25068640101"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0729978587015"
        ],
        "nui": [
          "N0000193956",
          "N0000008867",
          "N0000009560"
        ],
        "pharm_class_epc": [
          "Expectorant [EPC]"
        ],
        "pharm_class_pe": [
          "Decreased Respiratory Secretion Viscosity [PE]",
          "Increased Respiratory Secretions [PE]"
        ],
        "unii": [
          "9D2RTI9KYH",
          "495W7451VQ",
          "04JA59TNSJ"
        ]
      },
      "marketing_category": "UNAPPROVED DRUG OTHER",
      "dosage_form": "TABLET",
      "spl_id": "4485648d-222a-31b7-e063-6394a90a84e8",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20150310",
      "product_id": "29978-587_4485648d-222a-31b7-e063-6394a90a84e8",
      "brand_name_base": "Aquanaz",
      "pharm_class": [
        "Adrenergic alpha1-Agonists [MoA]",
        "Decreased Respiratory Secretion Viscosity [PE]",
        "Expectorant [EPC]",
        "Increased Respiratory Secretions [PE]",
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]",
        "alpha-1 Adrenergic Agonist [EPC]"
      ]
    }
  ]
}